Health & Safety Industry Today

Connective Tissue Disease Market to Demonstrate Progress at a ~11.5% of CAGR by 2023

In the coming years, it is expected that the Global Connective Tissue Disease Market will advance with higher growth rate as compared to previous years. Rising pressure to curb healthcare costs has fuelled the growth of the market for Connective Tissue Disease Market.
Published 23 January 2018 adds “Connective Tissue Disease Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

The report titled “Connective Tissue Disease Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Connective Tissue Disease Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! It is estimated that connective tissue disease market is expected to grow at a CAGR 11.5% during the forecast period of 2017-2023.

Regional Analysis of Global Connective Tissue Disease Market:
The Americas dominate the connective tissue disease market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), it is found that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States.

Europe holds the second position in the connective tissue disease market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.

Asia Pacific is the fastest growing connective tissue disease market owing to the huge patient pool, developing healthcare technology, and rising healthcare expenditure in some region. According to the Australian Institute of Health and Welfare, in the years 2015 and 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than expenditure of 2014–15.

The Middle East & Africa has the lowest market for connective tissue disease due to lack of technical knowledge and poor medical facilities.

Major Players in the Connective Tissue Disease Market:
Some of key the players in the market are Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd, Pfizer, AutoImmune Inc., Johnson & Johnson, Amgen Inc., AstraZeneca, Eli Lilly and Company, Biogen, LUPIN, and others.

Market Scenario of the Connective Tissue Disease Market:
Connective tissue disease is a group of medical diseases. Various connective tissue disorders feature abnormal immune system activity along with inflammation in tissues. Connective tissue disorders involves multiple organs and organ systems such as, skin, joints, muscles, lungs, kidneys, eyes, heart, gastrointestinal tract, and blood vessels.

According to a study published in Pan African Medical Journal in 2017, it is found that mixed connective tissue disorders are more frequent among Asians, and in the African population. It is also reported that among Asian population, the condition is more prevalent in China, and Japan. In the European region, the disorder is more prevalent in Italy, Hungary, Norway and Poland.

Rising prevalence of connective tissue disease, high unmet needs of current treatment, and increase in research and development expenditure will promote the growth of connective tissue disease market.

Lack of infrastructure in the middle and low income countries may hamper the growth of the market.


Segmentation of Global Connective Tissue Disease Market:
The connective tissue disease market is segmented on the basis of diagnosis, treatment, and end-user.

On the basis of diagnosis, market is segmented into physical examination, X-ray Examination, ANA (Antinuclear Antibody Test), and others.

On the basis of treatment, market is classified into non-steroidal anti-inflammatory drugs (NSAIDs), cortisone drugs/steroids, antimalarial drugs, cytotoxic drugs, and others

On the basis of end-user, market is segmented into hospital, diagnostic clinics, and others.

Major TOC of Connective Tissue Disease Market:
Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Connective Tissue Disease Market, By Diagnosis

Chapter 7. Global Connective Tissue Disease Market, By Treatment

Chapter 8. Global Connective Tissue Disease Market, By End User

Chapter 9. Global Connective Tissue Disease Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion

Chapter 13. Appendix



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, 
Pune – 411028
Maharashtra, India
+1 646 845 9312

Other Industry News

Ready to start publishing

Sign Up today!